England leads Europe with a new 5-minute cancer immunotherapy jab. The NHS introduces an injectable form of nivolumab, approved for 15 cancer types, enhancing patient convenience and optimizing healthcare resources. For more content like this, please visit: https://t.co/aarOCkIins #CancerTreatment# #Immunotherapy# #NHSInnovation# #Nivolumab#

The @FinancialTimes has run a piece highlighting UCLB spinout Autolus Therapeutics’ journey to produce therapies for cancer side effects 👏 The news story focuses on the work taking place at Autolus’ Stevenage facility, which is manufacturing the latest generation of an innovative, personalised cancer treatment: a new Car-T cell therapy to treat the blood cancer acute lymphoblastic leukaemia. 📖 Read more here: https://t.co/3IBqRtuZsL